TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
TVRD

Tvardi Therapeutics, Inc.

Healthcare · Biotechnology

1.60$ -6.4% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Cash Flow

Tvardi Therapeutics, Inc. (TVRD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -23 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow TVRD
Line item 2020 2021 2022 2023 2024 2025
-5.5 -60 -18 -92 -61 -23
1.0 1.6 0.1 0.3 0.2 0.1
0.2 0.3 0.3 1.4
-7.4 5.3 2.7 10 -15 0.5
0.3 0.0 0.1 2.4 1.0 0.0
-20 -4.8 -22 43 49 -10
28 0.0
39 47 0.0 38 -3.6 23
13 -18 -40 -12 -14 -11
-5.8 -60 -18 -94 -62 -23

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?